Showing 1 - 10 of 2,290
Persistent link: https://www.econbiz.de/10002481759
Persistent link: https://www.econbiz.de/10009580643
This paper compares the clinical trial strategies and performance of large, established ("mature") biopharmaceutical firms to those of smaller ("early stage") firms that have not yet successfully developed a drug. We study a sample of 235 cancer drug candidates that entered clinical trials...
Persistent link: https://www.econbiz.de/10012467754
Persistent link: https://www.econbiz.de/10013277585
Persistent link: https://www.econbiz.de/10013343552
This paper compares the clinical trial strategies and performance of large, established (quot;maturequot;) biopharmaceutical firms to those of smaller (quot;early stagequot;) firms that have not yet successfully developed a drug. We study a sample of 235 cancer drug candidates that entered...
Persistent link: https://www.econbiz.de/10012752635
Persistent link: https://www.econbiz.de/10010520776
Persistent link: https://www.econbiz.de/10011817857
Persistent link: https://www.econbiz.de/10011386079
Persistent link: https://www.econbiz.de/10003858288